Ischaemic mitral regurgitation in coronary revascularization: A critical gap in surgical guidelines

Rahul Bhushan1, Vijay Grover1

  • 1Department of CTVS, ABVIMS and Dr RML Hospital, New Delhi, 110001, India.

Insights

Managing ischemic mitral regurgitation (IMR) with coronary artery disease (CAD) remains complex. Current evidence offers mixed results on surgical interventions, necessitating clearer guidelines for optimal patient outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Medicine

Background:

  • Ischemic mitral regurgitation (IMR) poses a significant clinical challenge, especially when co-occurring with coronary artery disease (CAD).
  • Treatment paradigms for IMR are evolving, yet controversies persist regarding the optimal surgical approach, leading to a lack of definitive clinical guidelines.
  • The management of IMR requires careful consideration due to its complexity and the ongoing debate surrounding surgical interventions.

Purpose of the Study:

  • To review and analyze the evolving discourse and treatment landscape for ischemic mitral regurgitation (IMR) from 2000 to 2020.
  • To elucidate the impact of various interventions, including coronary revascularization and mitral valve procedures, on patient outcomes in IMR.
  • To identify the persistent ambiguities in IMR management guidelines and the need for evidence-based recommendations.

Main Methods:

  • A comprehensive literature review of seminal studies published between 2000 and 2020 was conducted.
  • Studies focusing on interventions for IMR, such as coronary artery bypass grafting (CABG) with or without mitral valve intervention, were critically evaluated.
  • Data on patient outcomes, adverse events, and recurrence rates following different surgical approaches were scrutinized.

Main Results:

  • Early studies presented conflicting views on the necessity of adjunct mitral valve intervention during CABG for IMR.
  • Subsequent trials (e.g., POINT, RIME) suggested benefits of concomitant mitral interventions, while the Cardiothoracic Surgical Trials Network (CTSN) trials raised concerns about adverse events and repair durability.
  • Current guidelines from organizations like the American Heart Association (AHA) offer moderate support but lack a clear consensus on mitral valve interventions for IMR.

Conclusions:

  • The optimal surgical management for ischemic mitral regurgitation (IMR) in patients with coronary artery disease (CAD) remains controversial.
  • Despite some evidence supporting concomitant mitral interventions, concerns regarding adverse events and recurrence persist, contributing to guideline ambiguity.
  • There is an imperative need for refined clinical guidelines based on current evidence to optimize treatment strategies and improve outcomes for IMR patients.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
51
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
81
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42